![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard |
100.023.805
![]() |
Chemical and physical data | |
Formula | C12H18N2 |
Molar mass | 190.290 g·mol−1 |
3D model ( JSmol) | |
| |
|
3-Methylbenzylpiperazine (3-Me-BZP) is a stimulant drug which is a derivative of benzylpiperazine. It has been sold as a designer drug, first being identified in Sweden in February 2012. [1]